Martin Shkreli, the bad boy of pharma, makes no apologies The Seattle Times

He’s become notorious for massively jacking up the prices of old, narrowly focused drugs, but the hedge-fund manager insists he’s plowing the profits into research for newer treatments.
http://www.seattletimes.com/business/martin-shkreli-the-bad-boy-of-pharma-makes-no-apologies/